← Back to Search

Implementation Strategy Training for Liver Cancer (OASIS Trial)

N/A
Waitlist Available
Led By Shari S. Rogal, MD MPH
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 4 weeks, 6 months post-intervention
Awards & highlights

OASIS Trial Summary

This trial seeks to bridge the gap between evidence-based healthcare and implementation, to improve quality & equity of medical care. #ImplementationScience

Who is the study for?
This trial is for veterans who've had recent medical care at a VA center and have liver cirrhosis or related complications, as well as healthcare providers involved in improving care at these centers. It's not for those who've had a liver transplant or currently have active liver cancer.Check my eligibility
What is being tested?
Project OASIS is testing a new decision aid tool against the current one to see which better identifies barriers and matches strategies to improve healthcare implementation. This study randomly assigns different VA centers to use either the new or current tool.See study design
What are the potential side effects?
Since this trial involves training on decision aid tools rather than medications, there are no direct physical side effects expected from participating in this study.

OASIS Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 4 weeks, 6 months post-intervention
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 4 weeks, 6 months post-intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Adoption as assessed by % improvement in HCC screening performance
Effectiveness as assessed by patient outcomes
Implementation as assessed by fidelity to HCC screening recommendations
+2 more
Secondary outcome measures
Acceptability of Intervention Measure (AIM)
Feasibility of Intervention Measure (FIM)
Intervention Appropriateness Measure (IAM)

OASIS Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: OASIS DAExperimental Treatment1 Intervention
Half of the sites will be randomized to receive training on the OASIS decision aid.
Group II: Current DA ToolActive Control1 Intervention
Half of the sites will be randomized to receive training on the current decision aid tool.

Find a Location

Who is running the clinical trial?

VA Palo Alto Health Care SystemFED
87 Previous Clinical Trials
48,843 Total Patients Enrolled
VA Ann Arbor Healthcare SystemFED
17 Previous Clinical Trials
5,028 Total Patients Enrolled
VA Pittsburgh Healthcare SystemFED
32 Previous Clinical Trials
3,389 Total Patients Enrolled
1 Trials studying Liver Cirrhosis
12 Patients Enrolled for Liver Cirrhosis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there opportunities available to join this clinical investigation?

"The record on clinicaltrials.gov affirms that this trial is not presently admitting patients; the initial post was made November 1st 2023, with the most recent update occurring September 27th 2023. However, there are currently 756 other trials actively recruiting volunteers."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
Project OASIS: Optimizing Approaches to Select Implementation Strategies
2024. "Project OASIS: Optimizing Approaches to Select Implementation Strategies". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06061328.
All > Liver Cirrhosis
~5347 spots leftby Oct 2027
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top